Molecular targeted therapy for advanced or metastatic soft tissue sarcoma
Soft tissue sarcomas are a form of rare and heterogeneous neoplasms with high recurrence rate and mortality. Over the past decades, less progress has been achieved. Surgical management with or without adjuvant/neoadjuvant radiotherapy is still the first-line treatment for localized soft tissue sarco...
Enregistré dans:
Auteurs principaux: | Jin Yuan MD, Xiaoyang Li MD, PhD, Shengji Yu MD |
---|---|
Format: | article |
Langue: | EN |
Publié: |
SAGE Publishing
2021
|
Sujets: | |
Accès en ligne: | https://doaj.org/article/9bcc089f4fd74fe2bc7610c1056457c1 |
Tags: |
Ajouter un tag
Pas de tags, Soyez le premier à ajouter un tag!
|
Documents similaires
-
Molecular profiling of advanced soft-tissue sarcomas: the MULTISARC randomized trial
par: Antoine Italiano, et autres
Publié: (2021) -
Predictive and prognostic transcriptomic biomarkers in soft tissue sarcomas
par: Eve Merry, et autres
Publié: (2021) -
Tumor Mutational Burden as a Biomarker for Advanced Biliary Tract Cancer
par: Hongsik Kim MD, et autres
Publié: (2021) -
Effect of Fuzheng Qingdu Therapy for Metastatic Gastric Cancer is Associated With Improved Survival: A Multicenter Propensity-Matched Study
par: Chao Hou MD, et autres
Publié: (2021) -
Efficacy of Targeted Inhibitors in Metastatic Lung Squamous Cell Carcinoma With EGFR or ALK Alterations
par: Whitney E. Lewis, PharmD, et autres
Publié: (2021)